{"id":2120,"date":"2026-07-09T22:49:00","date_gmt":"2026-07-09T22:49:00","guid":{"rendered":"https:\/\/futurenews24.com\/index.php\/2026\/07\/09\/epigenomic-analysis-uncovers-new-aml-subgroups-and-drug-sensitivities\/"},"modified":"2026-07-10T07:59:08","modified_gmt":"2026-07-10T07:59:08","slug":"epigenomic-analysis-uncovers-new-aml-subgroups-and-drug-sensitivities","status":"publish","type":"post","link":"https:\/\/futurenews24.com\/index.php\/2026\/07\/09\/epigenomic-analysis-uncovers-new-aml-subgroups-and-drug-sensitivities\/","title":{"rendered":"Epigenomic Evaluation Uncovers New AML Subgroups and Drug Sensitivities"},"content":{"rendered":"<p><br \/>\n<\/p>\n<div>\n<div class=\"td-post-featured-image\">\n<figure><img decoding=\"async\" width=\"696\" height=\"464\" class=\"entry-thumb td-modal-image\" src=\"https:\/\/www.genengnews.com\/wp-content\/uploads\/2023\/04\/GettyImages-514264276-696x464.jpg\" srcset=\"https:\/\/www.genengnews.com\/wp-content\/uploads\/2023\/04\/GettyImages-514264276-696x464.jpg 696w, https:\/\/www.genengnews.com\/wp-content\/uploads\/2023\/04\/GettyImages-514264276.jpg 1392w\" sizes=\"(-webkit-min-device-pixel-ratio: 2) 1392px, (min-resolution: 192dpi) 1392px, 696px\" alt=\"AML\" title=\"Getty-514264276\"\/><figcaption class=\"wp-caption-text\">AML has solely a 29 p.c survival price, and it\u2019s a fast-growing most cancers. It\u2019s typically widespread within the bone marrow and the blood when it\u2019s first found in a affected person, so having the ability to research the most cancers, its development, and its response to medication in correct and viable cell traces is essential. [Toeytoey2530\/Getty Images]<\/figcaption><\/figure>\n<\/div>\n<p>As one of the aggressive blood cancers, the best way acute myeloid leukemia (AML) is classed continues to form each main medical choice\u2014from threat stratification to the selection of focused therapies. For many years, that classification has rested nearly completely on the gene mutations present in leukemic cells. However mutations alone have by no means absolutely defined why AML behaves so in a different way from affected person to affected person. A brand new research revealed in Nature now gives the lacking layer: the epigenome.<\/p>\n<p>Within the largest chromatin\u2011profiling effort ever carried out for any most cancers, a analysis workforce led by Seishi Ogawa, MD, PhD, and Yotaro Ochi, MD, PhD, of Kyoto College, along with S\u00f6ren Lehmann, MD, PhD, of the Karolinska Institute, mapped the chromatin accessibility panorama of 1,563 AML affected person samples. Their evaluation\u2014constructed on ATAC\u2011seq, RNA\u2011seq, DNA methylation, ChIP\u2011seq, entire\u2011genome sequencing, and single\u2011cell multiomics\u2014reveals that AML could be labeled into 16 distinct epigenomic subgroups, every outlined by a attribute chromatin state and its personal regulatory wiring.<\/p>\n<p>Because the authors wrote, \u201cATAC-seq\u2026present[s] that AML could be labeled into 16 subgroups on the idea of chromatin accessibility profiles.\u201d This chromatin\u2011based mostly construction was remarkably steady: single\u2011cell ATAC\u2011seq throughout greater than 280,000 cells confirmed that every affected person\u2019s leukemic inhabitants shares a conserved accessibility fingerprint.<\/p>\n<p>Every subgroup carries a singular mixture of driver mutations, differentiation states, transcription\u2011issue networks, DNA methylation patterns, and tremendous\u2011enhancer structure. Many don&#8217;t align cleanly with present genomic classifications reminiscent of WHO or ICC, in accordance with the researchers. In truth, the workforce discovered that even exhaustive choice\u2011tree analyses of identified driver mutations couldn&#8217;t clarify most subgroup identities. Because the paper famous, \u201cProof means that genetic alterations don&#8217;t absolutely clarify AML pathophysiology and heterogeneity.\u201d<\/p>\n<p>Clinically, chromatin data sharpened prognostic evaluation in each Swedish and Japanese cohorts. A number of subgroups additionally confirmed surprising drug sensitivities. Three subgroups responded to MEK inhibitors regardless of missing RAS\u2011pathway mutations. One other subgroup, enriched for RUNX1 mutations and marked by a chromatin profile resembling early B\u2011cell precursors, proved extremely delicate to ABL inhibitors.<\/p>\n<p>The research, \u201cChromatin panorama and epigenetic heterogeneity of acute myeloid leukemia,\u201d positions chromatin structure as a foundational dimension of AML biology. It additionally gives a sensible path towards medical adoption: the workforce distilled a 30\u2011gene expression signature able to figuring out excessive\u2011threat chromatin subgroups utilizing normal sequencing workflows.<\/p>\n<p>Trying forward, the group goals to develop decrease\u2011value diagnostic approaches and refine remedy methods tailor-made to every epigenomic subgroup. The newly generated eCHROMA AML atlas is anticipated to function a useful resource for most cancers epigenomics broadly, enabling discovery of recent therapeutic targets and mechanistic insights.<\/p>\n<\/p><\/div>\n<p><br \/>\n<br \/><a href=\"https:\/\/www.genengnews.com\/topics\/cancer\/epigenomic-analysis-uncovers-new-aml-subgroups-and-drug-sensitivities\/\">Source link <\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>AML has solely a 29 p.c survival price, and it\u2019s a fast-growing most cancers. It\u2019s typically widespread within the bone marrow and the blood when it\u2019s first found in a affected person, so having the ability to research the most cancers, its development, and its response to medication in correct and viable cell traces is [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":2122,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"fifu_image_url":"https:\/\/www.genengnews.com\/wp-content\/uploads\/2023\/04\/GettyImages-514264276.jpg","fifu_image_alt":"","jnews-multi-image_gallery":[],"jnews_single_post":[],"jnews_primary_category":[],"jnews_override_bookmark_settings":[],"jnews_social_meta":[],"jnews_override_counter":[],"footnotes":""},"categories":[10],"tags":[2635,218,497,2633,2637,2636,2634],"class_list":["post-2120","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-biotechnology","tag-aml","tag-analysis","tag-drug","tag-epigenomic","tag-sensitivities","tag-subgroups","tag-uncovers"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Epigenomic Evaluation Uncovers New AML Subgroups and Drug Sensitivities - Future News 24<\/title>\n<meta name=\"description\" content=\"A 1,563\u2011sample chromatin atlas reveals 16 epigenomic subgroups of AML, redefining disease classification, prognosis, and therapeutic vulnerabilities.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/futurenews24.com\/index.php\/2026\/07\/09\/epigenomic-analysis-uncovers-new-aml-subgroups-and-drug-sensitivities\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Epigenomic Evaluation Uncovers New AML Subgroups and Drug Sensitivities - Future News 24\" \/>\n<meta property=\"og:description\" content=\"A 1,563\u2011sample chromatin atlas reveals 16 epigenomic subgroups of AML, redefining disease classification, prognosis, and therapeutic vulnerabilities.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/futurenews24.com\/index.php\/2026\/07\/09\/epigenomic-analysis-uncovers-new-aml-subgroups-and-drug-sensitivities\/\" \/>\n<meta property=\"og:site_name\" content=\"Future News 24\" \/>\n<meta property=\"article:published_time\" content=\"2026-07-09T22:49:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-07-10T07:59:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.genengnews.com\/wp-content\/uploads\/2023\/04\/GettyImages-514264276.jpg\" \/>\n<meta name=\"author\" content=\"Future News 24\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/www.genengnews.com\/wp-content\/uploads\/2023\/04\/GettyImages-514264276.jpg\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Future News 24\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/2026\\\/07\\\/09\\\/epigenomic-analysis-uncovers-new-aml-subgroups-and-drug-sensitivities\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/2026\\\/07\\\/09\\\/epigenomic-analysis-uncovers-new-aml-subgroups-and-drug-sensitivities\\\/\"},\"author\":{\"name\":\"Future News 24\",\"@id\":\"https:\\\/\\\/futurenews24.com\\\/#\\\/schema\\\/person\\\/cecad1bde21cfc357cf70128144d6c83\"},\"headline\":\"Epigenomic Evaluation Uncovers New AML Subgroups and Drug Sensitivities\",\"datePublished\":\"2026-07-09T22:49:00+00:00\",\"dateModified\":\"2026-07-10T07:59:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/2026\\\/07\\\/09\\\/epigenomic-analysis-uncovers-new-aml-subgroups-and-drug-sensitivities\\\/\"},\"wordCount\":534,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/futurenews24.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/2026\\\/07\\\/09\\\/epigenomic-analysis-uncovers-new-aml-subgroups-and-drug-sensitivities\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.genengnews.com\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/GettyImages-514264276.jpg\",\"keywords\":[\"AML\",\"Analysis\",\"drug\",\"Epigenomic\",\"Sensitivities\",\"Subgroups\",\"Uncovers\"],\"articleSection\":[\"BioTechnology\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/2026\\\/07\\\/09\\\/epigenomic-analysis-uncovers-new-aml-subgroups-and-drug-sensitivities\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/2026\\\/07\\\/09\\\/epigenomic-analysis-uncovers-new-aml-subgroups-and-drug-sensitivities\\\/\",\"url\":\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/2026\\\/07\\\/09\\\/epigenomic-analysis-uncovers-new-aml-subgroups-and-drug-sensitivities\\\/\",\"name\":\"Epigenomic Evaluation Uncovers New AML Subgroups and Drug Sensitivities - Future News 24\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/futurenews24.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/2026\\\/07\\\/09\\\/epigenomic-analysis-uncovers-new-aml-subgroups-and-drug-sensitivities\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/2026\\\/07\\\/09\\\/epigenomic-analysis-uncovers-new-aml-subgroups-and-drug-sensitivities\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.genengnews.com\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/GettyImages-514264276.jpg\",\"datePublished\":\"2026-07-09T22:49:00+00:00\",\"dateModified\":\"2026-07-10T07:59:08+00:00\",\"description\":\"A 1,563\u2011sample chromatin atlas reveals 16 epigenomic subgroups of AML, redefining disease classification, prognosis, and therapeutic vulnerabilities.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/2026\\\/07\\\/09\\\/epigenomic-analysis-uncovers-new-aml-subgroups-and-drug-sensitivities\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/2026\\\/07\\\/09\\\/epigenomic-analysis-uncovers-new-aml-subgroups-and-drug-sensitivities\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/2026\\\/07\\\/09\\\/epigenomic-analysis-uncovers-new-aml-subgroups-and-drug-sensitivities\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.genengnews.com\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/GettyImages-514264276.jpg\",\"contentUrl\":\"https:\\\/\\\/www.genengnews.com\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/GettyImages-514264276.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/2026\\\/07\\\/09\\\/epigenomic-analysis-uncovers-new-aml-subgroups-and-drug-sensitivities\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/futurenews24.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Epigenomic Evaluation Uncovers New AML Subgroups and Drug Sensitivities\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/futurenews24.com\\\/#website\",\"url\":\"https:\\\/\\\/futurenews24.com\\\/\",\"name\":\"Future News 24\",\"description\":\"The Smart Hub for AI and Next-Gen Innovation\",\"publisher\":{\"@id\":\"https:\\\/\\\/futurenews24.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/futurenews24.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/futurenews24.com\\\/#organization\",\"name\":\"Future News 24\",\"url\":\"https:\\\/\\\/futurenews24.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/futurenews24.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/futurenews24.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/fn24-favicon.png\",\"contentUrl\":\"https:\\\/\\\/futurenews24.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/fn24-favicon.png\",\"width\":250,\"height\":250,\"caption\":\"Future News 24\"},\"image\":{\"@id\":\"https:\\\/\\\/futurenews24.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/futurenews24.com\\\/#\\\/schema\\\/person\\\/cecad1bde21cfc357cf70128144d6c83\",\"name\":\"Future News 24\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/d57f07142d73cb5503ab2446ea7bc9ef3d0a5ba378d64a6157692311e42bf097?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/d57f07142d73cb5503ab2446ea7bc9ef3d0a5ba378d64a6157692311e42bf097?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/d57f07142d73cb5503ab2446ea7bc9ef3d0a5ba378d64a6157692311e42bf097?s=96&d=mm&r=g\",\"caption\":\"Future News 24\"},\"sameAs\":[\"https:\\\/\\\/futurenews24.com\"],\"url\":\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/author\\\/mridulpahuja20\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Epigenomic Evaluation Uncovers New AML Subgroups and Drug Sensitivities - Future News 24","description":"A 1,563\u2011sample chromatin atlas reveals 16 epigenomic subgroups of AML, redefining disease classification, prognosis, and therapeutic vulnerabilities.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/futurenews24.com\/index.php\/2026\/07\/09\/epigenomic-analysis-uncovers-new-aml-subgroups-and-drug-sensitivities\/","og_locale":"en_US","og_type":"article","og_title":"Epigenomic Evaluation Uncovers New AML Subgroups and Drug Sensitivities - Future News 24","og_description":"A 1,563\u2011sample chromatin atlas reveals 16 epigenomic subgroups of AML, redefining disease classification, prognosis, and therapeutic vulnerabilities.","og_url":"https:\/\/futurenews24.com\/index.php\/2026\/07\/09\/epigenomic-analysis-uncovers-new-aml-subgroups-and-drug-sensitivities\/","og_site_name":"Future News 24","article_published_time":"2026-07-09T22:49:00+00:00","article_modified_time":"2026-07-10T07:59:08+00:00","og_image":[{"url":"https:\/\/www.genengnews.com\/wp-content\/uploads\/2023\/04\/GettyImages-514264276.jpg","type":"","width":"","height":""}],"author":"Future News 24","twitter_card":"summary_large_image","twitter_image":"https:\/\/www.genengnews.com\/wp-content\/uploads\/2023\/04\/GettyImages-514264276.jpg","twitter_misc":{"Written by":"Future News 24","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/futurenews24.com\/index.php\/2026\/07\/09\/epigenomic-analysis-uncovers-new-aml-subgroups-and-drug-sensitivities\/#article","isPartOf":{"@id":"https:\/\/futurenews24.com\/index.php\/2026\/07\/09\/epigenomic-analysis-uncovers-new-aml-subgroups-and-drug-sensitivities\/"},"author":{"name":"Future News 24","@id":"https:\/\/futurenews24.com\/#\/schema\/person\/cecad1bde21cfc357cf70128144d6c83"},"headline":"Epigenomic Evaluation Uncovers New AML Subgroups and Drug Sensitivities","datePublished":"2026-07-09T22:49:00+00:00","dateModified":"2026-07-10T07:59:08+00:00","mainEntityOfPage":{"@id":"https:\/\/futurenews24.com\/index.php\/2026\/07\/09\/epigenomic-analysis-uncovers-new-aml-subgroups-and-drug-sensitivities\/"},"wordCount":534,"commentCount":0,"publisher":{"@id":"https:\/\/futurenews24.com\/#organization"},"image":{"@id":"https:\/\/futurenews24.com\/index.php\/2026\/07\/09\/epigenomic-analysis-uncovers-new-aml-subgroups-and-drug-sensitivities\/#primaryimage"},"thumbnailUrl":"https:\/\/www.genengnews.com\/wp-content\/uploads\/2023\/04\/GettyImages-514264276.jpg","keywords":["AML","Analysis","drug","Epigenomic","Sensitivities","Subgroups","Uncovers"],"articleSection":["BioTechnology"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/futurenews24.com\/index.php\/2026\/07\/09\/epigenomic-analysis-uncovers-new-aml-subgroups-and-drug-sensitivities\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/futurenews24.com\/index.php\/2026\/07\/09\/epigenomic-analysis-uncovers-new-aml-subgroups-and-drug-sensitivities\/","url":"https:\/\/futurenews24.com\/index.php\/2026\/07\/09\/epigenomic-analysis-uncovers-new-aml-subgroups-and-drug-sensitivities\/","name":"Epigenomic Evaluation Uncovers New AML Subgroups and Drug Sensitivities - Future News 24","isPartOf":{"@id":"https:\/\/futurenews24.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/futurenews24.com\/index.php\/2026\/07\/09\/epigenomic-analysis-uncovers-new-aml-subgroups-and-drug-sensitivities\/#primaryimage"},"image":{"@id":"https:\/\/futurenews24.com\/index.php\/2026\/07\/09\/epigenomic-analysis-uncovers-new-aml-subgroups-and-drug-sensitivities\/#primaryimage"},"thumbnailUrl":"https:\/\/www.genengnews.com\/wp-content\/uploads\/2023\/04\/GettyImages-514264276.jpg","datePublished":"2026-07-09T22:49:00+00:00","dateModified":"2026-07-10T07:59:08+00:00","description":"A 1,563\u2011sample chromatin atlas reveals 16 epigenomic subgroups of AML, redefining disease classification, prognosis, and therapeutic vulnerabilities.","breadcrumb":{"@id":"https:\/\/futurenews24.com\/index.php\/2026\/07\/09\/epigenomic-analysis-uncovers-new-aml-subgroups-and-drug-sensitivities\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/futurenews24.com\/index.php\/2026\/07\/09\/epigenomic-analysis-uncovers-new-aml-subgroups-and-drug-sensitivities\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/futurenews24.com\/index.php\/2026\/07\/09\/epigenomic-analysis-uncovers-new-aml-subgroups-and-drug-sensitivities\/#primaryimage","url":"https:\/\/www.genengnews.com\/wp-content\/uploads\/2023\/04\/GettyImages-514264276.jpg","contentUrl":"https:\/\/www.genengnews.com\/wp-content\/uploads\/2023\/04\/GettyImages-514264276.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/futurenews24.com\/index.php\/2026\/07\/09\/epigenomic-analysis-uncovers-new-aml-subgroups-and-drug-sensitivities\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/futurenews24.com\/"},{"@type":"ListItem","position":2,"name":"Epigenomic Evaluation Uncovers New AML Subgroups and Drug Sensitivities"}]},{"@type":"WebSite","@id":"https:\/\/futurenews24.com\/#website","url":"https:\/\/futurenews24.com\/","name":"Future News 24","description":"The Smart Hub for AI and Next-Gen Innovation","publisher":{"@id":"https:\/\/futurenews24.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/futurenews24.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/futurenews24.com\/#organization","name":"Future News 24","url":"https:\/\/futurenews24.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/futurenews24.com\/#\/schema\/logo\/image\/","url":"https:\/\/futurenews24.com\/wp-content\/uploads\/2026\/06\/fn24-favicon.png","contentUrl":"https:\/\/futurenews24.com\/wp-content\/uploads\/2026\/06\/fn24-favicon.png","width":250,"height":250,"caption":"Future News 24"},"image":{"@id":"https:\/\/futurenews24.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/futurenews24.com\/#\/schema\/person\/cecad1bde21cfc357cf70128144d6c83","name":"Future News 24","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/d57f07142d73cb5503ab2446ea7bc9ef3d0a5ba378d64a6157692311e42bf097?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/d57f07142d73cb5503ab2446ea7bc9ef3d0a5ba378d64a6157692311e42bf097?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/d57f07142d73cb5503ab2446ea7bc9ef3d0a5ba378d64a6157692311e42bf097?s=96&d=mm&r=g","caption":"Future News 24"},"sameAs":["https:\/\/futurenews24.com"],"url":"https:\/\/futurenews24.com\/index.php\/author\/mridulpahuja20\/"}]}},"_links":{"self":[{"href":"https:\/\/futurenews24.com\/index.php\/wp-json\/wp\/v2\/posts\/2120","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/futurenews24.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/futurenews24.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/futurenews24.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/futurenews24.com\/index.php\/wp-json\/wp\/v2\/comments?post=2120"}],"version-history":[{"count":1,"href":"https:\/\/futurenews24.com\/index.php\/wp-json\/wp\/v2\/posts\/2120\/revisions"}],"predecessor-version":[{"id":2121,"href":"https:\/\/futurenews24.com\/index.php\/wp-json\/wp\/v2\/posts\/2120\/revisions\/2121"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/futurenews24.com\/index.php\/wp-json\/wp\/v2\/media\/2122"}],"wp:attachment":[{"href":"https:\/\/futurenews24.com\/index.php\/wp-json\/wp\/v2\/media?parent=2120"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/futurenews24.com\/index.php\/wp-json\/wp\/v2\/categories?post=2120"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/futurenews24.com\/index.php\/wp-json\/wp\/v2\/tags?post=2120"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}